10.32
price down icon4.44%   -0.48
after-market After Hours: 10.30 -0.02 -0.19%
loading
Benitec Biopharma Inc stock is traded at $10.32, with a volume of 30,950. It is down -4.44% in the last 24 hours and up +8.86% over the past month. Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$10.80
Open:
$10.7
24h Volume:
30,950
Relative Volume:
1.08
Market Cap:
$213.01M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-0.6091
EPS:
-16.9418
Net Cash Flow:
$-18.07M
1W Performance:
-4.71%
1M Performance:
+8.86%
6M Performance:
+15.31%
1Y Performance:
+167.36%
1-Day Range:
Value
$10.31
$10.80
1-Week Range:
Value
$10.30
$10.93
52-Week Range:
Value
$2.69
$12.89

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name
Name
Benitec Biopharma Inc
Name
Phone
(510) 780-0819
Name
Address
3940 TRUST WAY, HAYWARD, CA
Name
Employee
16
Name
Twitter
@BenitecLtd
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
BNTC's Discussions on Twitter

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-05-20 Downgrade Ladenburg Thalmann Buy → Neutral
Apr-20-20 Initiated Ladenburg Thalmann Buy
Feb-26-16 Downgrade Maxim Group Buy → Hold
Dec-31-15 Reiterated Maxim Group Buy
Sep-16-15 Reiterated Maxim Group Buy

Benitec Biopharma Inc Stock (BNTC) Latest News

pulisher
Nov 04, 2024

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewswire

Nov 04, 2024
pulisher
Oct 26, 2024

Long Term Trading Analysis for (BNTC) - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 26, 2024

Piper Sandler Initiates Coverage of Benitec Biopharma (BNTC) with Overweight Recommendation - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Janus Henderson Group PLC Expands Investment in Benitec Biopharm - GuruFocus.com

Oct 25, 2024
pulisher
Oct 25, 2024

Janus Henderson Group PLC Expands Investment in Benitec Biopharma Inc - Yahoo Finance

Oct 25, 2024
pulisher
Oct 19, 2024

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $19.50 Average Price Target from Analysts - Defense World

Oct 19, 2024
pulisher
Oct 17, 2024

Benitec Biopharma: OPMD Program Continues To Advance With Catalysts (NASDAQ:BNTC) - Seeking Alpha

Oct 17, 2024
pulisher
Oct 17, 2024

Q1 Earnings Estimate for BNTC Issued By Leerink Partnrs - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Benitec started at outperform by Oppenheimer on gene therapy potential (NASDAQ:BNTC) - Seeking Alpha

Oct 16, 2024
pulisher
Oct 16, 2024

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $19.50 Average Target Price from Analysts - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Oppenheimer Begins Coverage on Benitec Biopharma (NASDAQ:BNTC) - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

JMP Securities Increases Benitec Biopharma (NASDAQ:BNTC) Price Target to $18.00 - Defense World

Oct 16, 2024
pulisher
Oct 15, 2024

Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update - MarketBeat

Oct 15, 2024
pulisher
Oct 15, 2024

Benitec Biopharma Reports Promising Results for BB-301 Trial - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

Benitec Biopharma’s Oculopharyngeal Muscular Dystrophy Gene Therapy Produces Clinical Improvements in Swallowing in Phase 1b/2a Trial - CGTLive™

Oct 15, 2024
pulisher
Oct 14, 2024

Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Oct 14, 2024
pulisher
Oct 14, 2024

Gene Silencing Market to Expand with Significant CAGR by 2034 |Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pha – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 14, 2024

JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $18.00 - MarketBeat

Oct 14, 2024
pulisher
Oct 14, 2024

Piper Sandler maintains Overweight rating on Benitec BioPharma stock By Investing.com - Investing.com UK

Oct 14, 2024
pulisher
Oct 14, 2024

Leerink reiterates Benitec BioPharma at Outperform following new BB-301 data - Investing.com Canada

Oct 14, 2024
pulisher
Oct 14, 2024

Benitec Biopharma Announces Updated Investor Webcast Information - GlobeNewswire

Oct 14, 2024
pulisher
Oct 14, 2024

Global Antisense & RNAi Therapeutics Market Growth in Future - openPR

Oct 14, 2024
pulisher
Oct 12, 2024

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase - The Bakersfield Californian

Oct 12, 2024
pulisher
Oct 12, 2024

Benitec Biopharma Reports Positive Data from Two Subjects - GlobeNewswire

Oct 12, 2024
pulisher
Oct 12, 2024

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society - StockTitan

Oct 12, 2024
pulisher
Oct 12, 2024

Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail

Oct 12, 2024
pulisher
Oct 12, 2024

Coinbase Global Inc Cl A (COIN-Q) QuotePress Release - The Globe and Mail

Oct 12, 2024
pulisher
Oct 10, 2024

RNAi Therapeutics Market Focusing on Trends and Innovations - openPR

Oct 10, 2024
pulisher
Oct 09, 2024

Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above Fifty Day Moving AverageShould You Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Benitec Biopharma's BB-301: Potential In OPMD, But Still Too Early Stages (NASDAQ:BNTC) - Seeking Alpha

Oct 09, 2024
pulisher
Oct 09, 2024

Benitec Biopharma Inc. Reports on Recent Stockholder Activity - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Benitec Biopharma issues shares after warrant exercises By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Benitec Biopharma issues shares after warrant exercises - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

5 Top NASDAQ Biotech Stocks of 2024 - Nasdaq

Oct 08, 2024
pulisher
Oct 05, 2024

When the Price of (BNTC) Talks, People Listen - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 04, 2024

Fresh Study Reveals the Duchenne Muscular Dystrophy Market Insights, Demand, and Forecast to 2033 - WhaTech

Oct 04, 2024
pulisher
Oct 03, 2024

Benitec Biopharma Stock (BNTC) Surges on Potentially Groundbreaking OPMD Treatment - Nasdaq

Oct 03, 2024
pulisher
Oct 02, 2024

Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth - Simply Wall St

Oct 02, 2024
pulisher
Oct 02, 2024

Benitec Biopharma stock soars to 52-week high of $10.9 By Investing.com - Investing.com South Africa

Oct 02, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Buys New Shares in Benitec Biopharma Inc. (NASDAQ:BNTC) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Benitec Biopharma stock soars to 52-week high of $10.9 - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Buys Shares of 841,395 Benitec Biopharma Inc. (NASDAQ:BNTC) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc - Yahoo Finance

Sep 30, 2024
pulisher
Sep 30, 2024

JMP Securities Reiterates Market Outperform Rating for Benitec Biopharma (NASDAQ:BNTC) - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

JMP Securities Reaffirms Market Outperform Rating for Benitec Biopharma (NASDAQ:BNTC) - MarketBeat

Sep 30, 2024
pulisher
Sep 28, 2024

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Sep 28, 2024
pulisher
Sep 28, 2024

Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Above 50 Day Moving Average of $8.85 - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Benitec Biopharma stock shows promise with OPMD treatment - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Benitec Biopharma stock shows promise with OPMD treatment By Investing.com - Investing.com South Africa

Sep 27, 2024
pulisher
Sep 26, 2024

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update - The Bakersfield Californian

Sep 26, 2024

Benitec Biopharma Inc Stock (BNTC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):